We are live on ! Find out more
BBHC

Brown Brothers Harriman & Co Portfolio holdings

AUM $18.6B
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
-10.55%
1 Year Est. Return
+15.81%
3 Year Est. Return
+66.02%
5 Year Est. Return
+80.97%
10 Year Est. Return
+273.41%
AUM
$13.2B
AUM Growth
-$2.92B
Cap. Flow
-$1.2B
Cap. Flow %
-9.07%
Top 10 Hldgs %
45.8%
Holding
1,027
New
215
Increased
199
Reduced
206
Closed
82

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$360M
2
CPRT icon
Copart
CPRT
+$281M
3
KLAC icon
KLA
KLAC
+$149M
4
BF.B icon
Brown-Forman Class B
BF.B
+$103M
5
DG icon
Dollar General
DG
+$96.8M

Sector Composition

Rank Sector Weight
1 Financials 21.3%
2 Technology 18.51%
3 Healthcare 12.57%
4 Communication Services 12.5%
5 Consumer Staples 11.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JD icon
151
JD.com
JD
$44.5B
$1.81M 0.01%
86,517
OXY icon
152
Occidental Petroleum
OXY
$55.9B
$1.8M 0.01%
29,332
-2,641
-8% -$186K
LLY icon
153
Eli Lilly
LLY
$1.06T
$1.75M 0.01%
15,135
+624
+4% +$69.7K
GLD icon
154
SPDR Gold Trust
GLD
$142B
$1.74M 0.01%
14,385
TFC icon
155
Truist Financial
TFC
$64B
$1.74M 0.01%
40,114
-859
-2% -$41.2K
COP icon
156
ConocoPhillips
COP
$141B
$1.71M 0.01%
27,470
+147
+0.5% +$10K
RTN
157
DELISTED
Raytheon Company
RTN
$1.7M 0.01%
11,105
-1,275
-10% -$228K
IWF icon
158
iShares Russell 1000 Growth ETF
IWF
$128B
$1.62M 0.01%
49,460
-464
-0.9% -$16.4K
SHW icon
159
Sherwin-Williams
SHW
$89.8B
$1.58M 0.01%
12,033
+183
+2% +$24.7K
SLB icon
160
SLB Ltd
SLB
$75B
$1.57M 0.01%
43,498
-4,344
-9% -$214K
AEP icon
161
American Electric Power
AEP
$68.4B
$1.56M 0.01%
20,911
-3,504
-14% -$263K
CCOI icon
162
Cogent Communications
CCOI
$508M
$1.52M 0.01%
33,536
LMT icon
163
Lockheed Martin
LMT
$136B
$1.5M 0.01%
5,720
+259
+5% +$78.6K
IT icon
164
Gartner
IT
$11.7B
$1.49M 0.01%
11,659
+733
+7% +$106K
TMO icon
165
Thermo Fisher Scientific
TMO
$220B
$1.48M 0.01%
6,607
-577
-8% -$135K
PRTK
166
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.48M 0.01%
287,902
SRPT icon
167
Sarepta Therapeutics
SRPT
$1.77B
$1.46M 0.01%
13,370
EPD icon
168
Enterprise Products Partners
EPD
$81.7B
$1.39M 0.01%
56,491
+9,772
+21% +$262K
TRIP icon
169
TripAdvisor
TRIP
$1.26B
$1.37M 0.01%
25,317
WOR icon
170
Worthington Enterprises
WOR
$2.86B
$1.34M 0.01%
62,359
AJG icon
171
Arthur J. Gallagher & Co
AJG
$63.6B
$1.33M 0.01%
18,071
+909
+5% +$67.9K
WDAY icon
172
Workday
WDAY
$44.4B
$1.33M 0.01%
8,324
MDU icon
173
MDU Resources
MDU
$4.32B
$1.31M 0.01%
144,928
IEFA icon
174
iShares Core MSCI EAFE ETF
IEFA
$196B
$1.3M 0.01%
23,666
+141
+0.6% +$8.27K
LUMN icon
175
Lumen
LUMN
$6.44B
$1.27M 0.01%
83,620
-239
-0.3% -$4.56K

Similar funds

Brown Brothers Harriman & Co's Q4 2018 Portfolio in Review

As of Q4 2018, Brown Brothers Harriman & Co held 1,027 positions worth $13.2B, down 18% from $16.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Brown Brothers Harriman & Co withdrew a net $1.2B in Q4 2018, closing 82 positions and reducing 206 holdings. Its most notable exit was Praxair Inc, an estimated $435M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Brown Brothers Harriman & Co opened a new position in Linde worth $356M.

  • Brown Brothers Harriman & Co's largest Q4 2018 buy was Linde: 2,280,313 shares worth $356M.
  • Brown Brothers Harriman & Co added most to Copart in Q4 2018, an estimated $281M increase.
  • Brown Brothers Harriman & Co's biggest Q4 2018 reduction was Wells Fargo, cutting an estimated $235M.
  • Brown Brothers Harriman & Co fully exited Praxair Inc in Q4 2018, selling an estimated $435M.
  • Brown Brothers Harriman & Co's ten largest holdings make up 46% of its $13.2B portfolio in Q4 2018.
  • Brown Brothers Harriman & Co opened 215 new positions and closed 82 in Q4 2018.
  • Brown Brothers Harriman & Co's portfolio value fell 18% quarter-over-quarter to $13.2B.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2018, filed 14 Feb 2019.